These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
451 related items for PubMed ID: 8635038
21. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomized, open-labeled, phase II trial. Vijayakumar S, Roach M, Wara W, Chan SK, Ewing C, Rubin S, Sutton H, Halpern H, Awan A, Houghton A. Int J Radiat Oncol Biol Phys; 1993 Jul 15; 26(4):721-9. PubMed ID: 8331011 [Abstract] [Full Text] [Related]
24. Once-weekly epoetin-beta improves hemoglobin levels in cancer patients with chemotherapy-induced anemia: A randomized, double-blind, dose-finding study. Morishima Y, Ogura M, Yoneda S, Sakai H, Tobinai K, Nishiwaki Y, Minami H, Hotta T, Ezaki K, Ohe Y, Yokoyama A, Tsuboi M, Mori K, Watanabe K, Ohashi Y, Hirashima K, Saijo N, Japan Erythropoietin Study Group. Jpn J Clin Oncol; 2006 Oct 15; 36(10):655-61. PubMed ID: 16987908 [Abstract] [Full Text] [Related]
33. An extended maintenance dosing regimen of epoetin alfa 80,000 U every 3 weeks in anemic patients with cancer receiving chemotherapy. Montoya VP, Xie J, Williams D, Woodman RC, Wilhelm FE. Support Care Cancer; 2007 Dec 15; 15(12):1385-92. PubMed ID: 17541653 [Abstract] [Full Text] [Related]
34. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS). Marques da Costa R. Sangre (Barc); 1994 Apr 15; 39(2):105-10. PubMed ID: 8059287 [Abstract] [Full Text] [Related]
35. A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy. Glaspy J, Jadeja JS, Justice G, Kessler J, Richards D, Schwartzberg L, Rigas J, Kuter D, Harmon D, Prow D, Demetri G, Gordon D, Arseneau J, Saven A, Hynes H, Boccia R, O'Byrne J, Colowick AB. Br J Cancer; 2001 Apr 15; 84 Suppl 1(Suppl 1):17-23. PubMed ID: 11308270 [Abstract] [Full Text] [Related]
36. Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 microg every 2 weeks) in anemic patients with cancer receiving chemotherapy. Waltzman R, Croot C, Justice GR, Fesen MR, Charu V, Williams D. Oncologist; 2005 Sep 15; 10(8):642-50. PubMed ID: 16177289 [Abstract] [Full Text] [Related]
37. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum. Tsai JC, Lai YH, Tsai ZY, Chien LJ, Tsai JH. Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar 15; 7(3):126-35. PubMed ID: 1865507 [Abstract] [Full Text] [Related]
38. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration]. Zehnder C, Blumberg A. Schweiz Med Wochenschr; 1990 Feb 17; 120(7):217-20. PubMed ID: 2309110 [Abstract] [Full Text] [Related]
39. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence. Crawford J. Oncology (Williston Park); 2002 Sep 17; 16(9 Suppl 10):41-53. PubMed ID: 12380954 [Abstract] [Full Text] [Related]